The Protective Effects of Acetylsalicylic Acid on Free Radical Production in Cisplatin Induced Nephrotoxicity: An Experimental Rat Model

• Published in: Drug and chemical toxicology (New York, N.Y. 1978) N.Y. 1978), 2003-01, Vol.26 (4), p.259-270
• Main Authors: Uluba, Bahar, Burak Ç men, M. Y., Dü mez Apa, Duygu, Sarita, Emel, Mu lu, Necat, Bölgen Ç men, Özlem
• Format: Article
• Language: English
• Subjects: Acetylsalicylic acid; Animals; Anti-Inflammatory Agents, Non-Steroidal - pharmacology; Antineoplastic Agents - toxicity; Antioxidant status; Aspirin - pharmacology; Biological and medical sciences; Cisplatin; Cisplatin - toxicity; Disease Models, Animal; Drug toxicity and drugs side effects treatment; Free Radical Scavengers - pharmacology; Free Radicals; Injections, Intraperitoneal; Kidney - drug effects; Kidney - pathology; Male; Medical sciences; Nephrotoxicity; Pharmacology. Drug treatments; Rats; Rats, Wistar; Toxicity: urogenital system
• ISSN: 0148-0545; 1525-6014
• DOI: 10.1081/DCT-120024841

Abstract Cisplatin-induced nephrotoxicity is closely associated with an increase in lipid peroxidation. In several previous reports it was claimed that acetylsalicylic acid (ASA) shows its therapeutic potential as a free radical scavenger. The aim of the study was to investigate effects of ASA on cisplatin induced nephrotoxicity in an experimental rat model. Control animals (n:7) were administered 1 mL saline solution intraperitoneal (i.p.). Cisplatin group (n:7) was treated with a single dose of cisplatin i.p. (6 mg kg), ASA group (n:7) was treated with i.p. (2.5 mg kg) per day during the study, cisplatin plus ASA group (n:7) was administered single dose cisplatin i.p. (6 mg kg) plus ASA (2.5 mg kg) during 5 days. At the end of the study, Catalase (CAT), Glutathione Peroxidase (GSH-Px), Superoxide Dismutase (SOD), Nitric Oxide Synthase (NOS) enzymes activities and Malondialdehyde (MDA), Antioxidant Potential (AOP) levels were measured in both erythrocytes and renal tissues. Urea and creatinine levels and renal tissue necrosis in cisplatin plus ASA group were significantly lower than cisplatin group (p = 0.000, p = 0.014, p = 0.015). SODr activities and MDAr levels of cisplatin plus ASA group were also significantly lower than cisplatin group (p = 0.000, p = 0.029). These results show that cisplatin and ASA combination decreases the levels of urea and creatinine, reduces necrosis and improves antioxidant enzyme activities, MDA and AOP in rat kidney.